This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Bheemreddy Rajini Devi: Innovator in Cataract Management
Introduction
Bheemreddy Rajini Devi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medical science, particularly in the management of cataracts. His innovative approach has led to the development of a unique method that addresses a critical aspect of eye health.
Latest Patents
Bheemreddy holds a patent for a method of identifying calcium-binding sites in gamma-crystallin, which is useful for the management of cataracts. This invention involves isolating gamma-crystallin from the eye lens and studying the binding of calcium to the isolated protein through both direct and indirect methods. The method identifies the Greek key motif as calcium-binding sites of the protein gamma-crystallin, with the protein binding 4-mol eq of calcium and having a dissociation constant of 90 micromoles. This patent represents a significant advancement in calcium-based homeostasis for cataract management.
Career Highlights
Bheemreddy Rajini Devi is associated with the Council of Scientific and Industrial Research, where he has been able to apply his research and innovations effectively. His work has garnered attention for its potential impact on eye health and cataract treatment.
Collaborations
Bheemreddy collaborates with Yogendra Kumar Sharma, who is also involved in research and development in related fields. Their partnership enhances the scope of their work and contributes to advancements in medical science.
Conclusion
Bheemreddy Rajini Devi's contributions to cataract management through his innovative patent highlight the importance of research in improving health outcomes. His work exemplifies the potential of scientific inquiry to address pressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
